DeAngelis, Lisa M.

Publications

Sort by

Co-Author Network

selected publications

Genetic variants and cognitive functions in patients with brain tumors. Neuro-oncology. 2019 Academic Article GET IT
Times cited: 17
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile. Stroke. 2019 Academic Article GET IT
Times cited: 9
Letter: When Less is More: Dexamethasone Dosing for Brain Tumors. Neurosurgery. 2019 Academic Article GET IT
Times cited: 14
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. Journal of neuro-oncology. 2019 Academic Article GET IT
Times cited: 36
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma. Journal of neuro-oncology. 2019 Academic Article GET IT
Times cited: 31
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 69
Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 2019 Academic Article GET IT
Times cited: 35
Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience. Neurology. 2019 Academic Article GET IT
Times cited: 31
Global consequences of malignant CNS tumours: a call to action. The Lancet. Neurology. 2019 Comment GET IT
Times cited: 4
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro-oncology. 2019 Review GET IT
Times cited: 82
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 82
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature. 2019 Academic Article GET IT
Times cited: 268
Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature genetics. 2019 Academic Article GET IT
Times cited: 1996
Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood. 2018 Academic Article GET IT
Times cited: 109
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 123
BRAF Inhibition in BRAF^V600-Mutant Gliomas: Results From the VE-BASKET Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 201
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab. 2018 GET IT
Times cited: 89
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 72
Letter to the Editor Regarding "National Trends for Reoperation in Older Patients with Glioblastoma". World neurosurgery. 2018 Letter GET IT
Times cited: 2
Ability of the Khorana score to predict recurrent thromboembolism in cancer patients with ischemic stroke. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2018 Academic Article GET IT
Times cited: 2
Improving outcomes in primary CNS lymphoma. Best practice & research. Clinical haematology. 2018 Review GET IT
Times cited: 14
The trials of neuro-oncology clinical research. Neuro-oncology. 2018 Comment GET IT
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-oncology. 2018 Review GET IT
Times cited: 31
Metastatic Complications of Cancer Involving the Central and Peripheral Nervous Systems. Neurologic clinics. 2018 Review GET IT
Times cited: 8
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. Cancer discovery. 2018 Academic Article GET IT
Times cited: 478
Metabolic Imaging of the Human Brain with Hyperpolarized ¹³C Pyruvate Demonstrates ¹³C Lactate Production in Brain Tumor Patients. Cancer research. 2018 Academic Article GET IT
Times cited: 146
New diagnosis of cancer and the risk of subsequent cerebrovascular events. Neurology. 2018 Academic Article GET IT
Times cited: 28
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 28
Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 7
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro-oncology. 2018 Academic Article GET IT
Times cited: 117
Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial. JAMA neurology. 2018 Academic Article GET IT
Times cited: 41
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab. CNS oncology. 2018 Academic Article GET IT
Times cited: 3
Reply: Arterial Thromboembolism in Non-Hodgkin Lymphoma, as the Presentation of Occult Cancer, and With Cancer Therapies. Journal of the American College of Cardiology. 2018 Letter GET IT
Times cited: 4
Overview of metastatic disease of the central nervous system. Handbook of clinical neurology. 2018 Review GET IT
Times cited: 25
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas. Journal of neuro-oncology. 2017 Academic Article GET IT
Times cited: 11
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Neuro-oncology. 2017 Academic Article GET IT
Times cited: 46
Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood advances. 2017 Academic Article GET IT
Times cited: 28
Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. Journal of neuro-oncology. 2017 Academic Article GET IT
Times cited: 22
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02. Journal of neuro-oncology. 2017 Academic Article GET IT
Times cited: 18
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro-oncology. 2017 Academic Article GET IT
Times cited: 21
Novel Considerations in the Approach to Glioblastoma. Journal of oncology practice. 2017 Comment GET IT
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Neuro-oncology. 2017 Academic Article GET IT
Times cited: 57
Increased risk of arterial thromboembolism in older men with breast cancer. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 7
Risk of Arterial Thromboembolism in Patients With Cancer. Journal of the American College of Cardiology. 2017 Academic Article GET IT
Times cited: 366
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma. International journal of radiation oncology, biology, physics. 2017 Academic Article GET IT
Times cited: 36
Primary CNS Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Review GET IT
Times cited: 290
Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2017 Academic Article GET IT
Times cited: 13
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. Cancer discovery. 2017 Academic Article GET IT
Times cited: 243
Reappraising the 2016 WHO classification for diffuse glioma. Neuro-oncology. 2017 Comment GET IT
Times cited: 5
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro-oncology. 2017 Review GET IT
Times cited: 101
Longitudinal analysis of treatment-induced genomic alterations in gliomas. 2017 GET IT
Times cited: 16
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas. Journal of neuro-oncology. 2017 Academic Article GET IT
Times cited: 16
Fertility preservation in primary brain tumor patients. Neuro-oncology practice. 2016 Academic Article GET IT
Times cited: 15
The confused oncologic patient: a rational clinical approach. Current opinion in neurology. 2016 Review GET IT
Times cited: 8
Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma. Journal of pain and symptom management. 2016 Academic Article GET IT
Times cited: 18
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 17
Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 23
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-oncology. 2016 Review GET IT
Times cited: 82
Correction regarding data on blinatumomab-associated seizures. Nature reviews. Clinical oncology. 2016 Letter GET IT
Times cited: 1
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 241
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 78
Is there a role for early chemotherapy in the management of pituitary adenomas?. Neuro-oncology. 2016 Review GET IT
Times cited: 21
COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. Neuro-oncology. 2016 Academic Article GET IT
Times cited: 38
OC-02 - Risk of arterial thromboembolism in patients with breast cancer. Thrombosis research. 2016 Academic Article GET IT
Chemotherapy-Induced Peripheral Neuropathy. Oncology (Williston Park, N.Y.). 2016 Academic Article GET IT
Times cited: 2
Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study. Journal of neuro-oncology. 2016 Academic Article GET IT
Times cited: 25
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. PloS one. 2016 Academic Article GET IT
Times cited: 15
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro-oncology. 2015 Academic Article GET IT
Times cited: 139
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria. 2015 GET IT
Times cited: 16
Cancer-treatment-induced neurotoxicity--focus on newer treatments. Nature reviews. Clinical oncology. 2015 Review GET IT
Times cited: 151
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer. Cancer. 2015 Academic Article GET IT
Times cited: 14
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 11
Treatment of Brain Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Review GET IT
Times cited: 261
Rates and risks for late referral to hospice in patients with primary malignant brain tumors. Neuro-oncology. 2015 Academic Article GET IT
Times cited: 58
Posterior Reversible Encephalopathy Syndrome in Patients With Cancer. The oncologist. 2015 Academic Article GET IT
Times cited: 67
Neuro-oncology: Primary CNS lymphoma treatment--the devil is in the details. Nature reviews. Neurology. 2015 Comment GET IT
Times cited: 4
Radiotherapy and temozolomide for anaplastic astrocytic gliomas. Journal of neuro-oncology. 2015 Academic Article GET IT
Times cited: 6
Diagnostic yield of echocardiography in cancer patients with ischemic stroke. Journal of neuro-oncology. 2015 Academic Article GET IT
Times cited: 21
Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneapolis, Minn.). 2015 Review GET IT
Times cited: 29
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Neuro-oncology. 2015 Academic Article GET IT
Times cited: 91
Association between incident cancer and subsequent stroke. Annals of neurology. 2015 Academic Article GET IT
Times cited: 147
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 225
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. 2014 GET IT
Times cited: 70
Emerging therapies for glioblastoma. JAMA neurology. 2014 Review GET IT
Times cited: 135
The double-edged sword: Neurotoxicity of chemotherapy. Blood reviews. 2014 Review GET IT
Times cited: 96
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 78
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro-oncology. 2014 Academic Article GET IT
Times cited: 182
Whither whole brain radiotherapy for primary CNS lymphoma?. Neuro-oncology. 2014 Review GET IT
Times cited: 19
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro-oncology. 2014 Academic Article GET IT
Times cited: 12
Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke. Stroke. 2014 Academic Article GET IT
Times cited: 67
Endovascular therapy for acute stroke in patients with cancer. The Neurohospitalist. 2014 Academic Article GET IT
Times cited: 18
APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology. 2014 Academic Article GET IT
Times cited: 46
Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology. 2014 Academic Article GET IT
Times cited: 111
Multimodality imaging of primary CNS lymphoma in immunocompetent patients. The British journal of radiology. 2014 Review GET IT
Times cited: 40
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma. British journal of haematology. 2014 Review GET IT
Times cited: 23
Methotrexate re-challenge for recurrent primary central nervous system lymphoma. Journal of neuro-oncology. 2014 Academic Article GET IT
Times cited: 70
The role of ventriculoperitoneal shunting in patients with supratentorial glioma. Annals of clinical and translational neurology. 2013 Academic Article GET IT
Times cited: 13
Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013 Review GET IT
Times cited: 1574
Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013 Academic Article GET IT
Times cited: 56
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 324
Central nervous system cancers. 2013 GET IT
Times cited: 52
Molecular interactions in the development of brain metastases. International journal of molecular sciences. 2013 Review GET IT
Times cited: 10
Spectrum of nonconvulsive status epilepticus in patients with cancer. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2013 Academic Article GET IT
Times cited: 18
Management of elderly patients with primary central nervous system lymphoma. Current neurology and neuroscience reports. 2013 Review GET IT
Times cited: 11
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology. 2013 Academic Article GET IT
Times cited: 75
Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2013 Academic Article GET IT
Times cited: 24
Steroid management in newly diagnosed glioblastoma. Journal of neuro-oncology. 2013 Academic Article GET IT
Times cited: 31
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept. Targeted oncology. 2013 Academic Article GET IT
Times cited: 7
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-oncology. 2012 Academic Article GET IT
Times cited: 87
MEF promotes stemness in the pathogenesis of gliomas. Cell stem cell. 2012 Academic Article GET IT
Times cited: 34
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro-oncology. 2012 Academic Article GET IT
Times cited: 91
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor. 2012 GET IT
Times cited: 23
Post-treatment T1 shortening in primary CNS lymphoma. Journal of neuro-oncology. 2012 Academic Article GET IT
Times cited: 1
Glioblastoma: molecular analysis and clinical implications. Annual review of medicine. 2012 Academic Article GET IT
Times cited: 75
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center. Neuro-oncology. 2012 Academic Article GET IT
Times cited: 52
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease. Journal of neuro-oncology. 2012 Academic Article GET IT
Times cited: 43
Intracranial hemorrhage in patients with cancer. Current atherosclerosis reports. 2012 Review GET IT
Times cited: 62
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 58
Subdural hematoma in patients with cancer. Neurosurgery. 2012 Academic Article GET IT
Times cited: 25
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro-oncology. 2012 Academic Article GET IT
Times cited: 52
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer. 2012 Academic Article GET IT
Times cited: 82
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer discovery. 2012 Academic Article GET IT
Times cited: 246
Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2012 Academic Article GET IT
Times cited: 203
Primary central nervous system lymphoma. Handbook of clinical neurology. 2012 Review GET IT
Times cited: 1
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors. Journal of neuro-oncology. 2011 Academic Article GET IT
Times cited: 14
Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. Journal of neuro-oncology. 2011 Academic Article GET IT
Times cited: 15
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer research. 2011 Academic Article GET IT
Times cited: 42
Virchow 2011 or how to ID(H) human glioblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
Times cited: 17
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 145
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer discovery. 2011 Academic Article GET IT
Times cited: 271
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 67
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia. 2011 Review GET IT
Times cited: 151
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 85
It is time to include patients with brain tumors in phase I trials in oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 17
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. Journal of neuro-oncology. 2011 Academic Article GET IT
Times cited: 104
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. Journal of neuro-oncology. 2011 Academic Article GET IT
Times cited: 21
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy. Leukemia & lymphoma. 2011 Academic Article GET IT
Times cited: 10
Herpes simplex encephalitis in patients with cancer. Journal of neuro-oncology. 2011 Academic Article GET IT
Times cited: 39
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 136
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 52
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 186
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 62
Central nervous system cancers. 2011 GET IT
Times cited: 85
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma. Annals of neurology. 2011 Academic Article GET IT
Times cited: 22
Late relapse in primary central nervous system lymphoma: clonal persistence. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 40
Radiotherapy: has the role of WBRT in primary CNS lymphoma been settled?. Nature reviews. Clinical oncology. 2011 Academic Article GET IT
Times cited: 11
Whole-brain radiotherapy in primary CNS lymphoma. The Lancet. Oncology. 2011 Letter GET IT
Times cited: 34
Leptomeningeal metastases in the MRI era. Neurology. 2011 Letter GET IT
Times cited: 16
Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy. Cancer. 2010 Academic Article GET IT
Times cited: 8
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 27
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer. 2010 Academic Article GET IT
Times cited: 47
Leptomeningeal metastases in the MRI era. Neurology. 2010 Academic Article GET IT
Times cited: 296
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro-oncology. 2010 Academic Article GET IT
Times cited: 167
Janeway lesions, osler nodes, or neither?. Archives of neurology. 2010 Letter GET IT
Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010 Academic Article GET IT
Times cited: 86
Neuro-oncology: new hope for patients with gliomas. The Lancet. Neurology. 2010 Academic Article GET IT
Times cited: 1
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Science signaling. 2009 Academic Article GET IT
Times cited: 261
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro-oncology. 2009 Academic Article GET IT
Times cited: 39
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-oncology. 2009 Academic Article GET IT
Times cited: 218
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-oncology. 2009 Academic Article GET IT
Times cited: 118
Bevacizumab for recurrent ependymoma. Neurology. 2009 Academic Article GET IT
Times cited: 53
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Editorial Article GET IT
Times cited: 40
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology. 2009 Academic Article GET IT
Times cited: 251
Multifocal stroke from tumor emboli. 2009 GET IT
Times cited: 26
Natalizumab: a double-edged sword?. Annals of neurology. 2009 Editorial Article GET IT
Times cited: 6
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. Journal of neuro-oncology. 2009 Academic Article GET IT
Times cited: 146
Neurological outcome of long-term glioblastoma survivors. Journal of neuro-oncology. 2009 Academic Article GET IT
Times cited: 63
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 155
Primary central nervous system lymphoma: coming or going?. Blood. 2009 Comment GET IT
Times cited: 8
Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery. 2009 Academic Article GET IT
Times cited: 107
Sarcoidosis presenting as brainstem ischemic stroke. 2009 GET IT
Times cited: 15
Therapy of chemotherapy-induced peripheral neuropathy. British journal of haematology. 2009 Review GET IT
Times cited: 136
Synchronous presentation of systemic and brain non-Hodgkin lymphoma. Leukemia & lymphoma. 2008 Letter GET IT
Times cited: 2
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. Journal of neuro-oncology. 2008 Academic Article GET IT
Times cited: 95
Utility of brain FDG-PET in primary CNS lymphoma. Clinical advances in hematology & oncology : H&O. 2008 Academic Article GET IT
Times cited: 29
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas. Journal of neuro-oncology. 2008 Academic Article GET IT
Times cited: 64
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). Journal of neuro-oncology. 2008 Academic Article GET IT
Times cited: 86
Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer. 2008 Academic Article GET IT
Times cited: 64
Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma. Leukemia & lymphoma. 2008 Academic Article GET IT
Times cited: 19
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro-oncology. 2008 Review GET IT
Times cited: 28
Ischemic stroke in patients with primary brain tumors. Neurology. 2008 Academic Article GET IT
Times cited: 62
Central nervous system cancers. 2008 GET IT
Times cited: 31
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro-oncology. 2008 Academic Article GET IT
Times cited: 347
The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-oncology. 2008 Academic Article GET IT
Times cited: 110
Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer. 2008 Academic Article GET IT
Times cited: 66
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 68
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 20
Brain metastases. Neurologic clinics. 2007 Review GET IT
Times cited: 30
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 316
Longitudinal cognitive follow-up in low grade gliomas. Journal of neuro-oncology. 2007 Academic Article GET IT
Times cited: 79
Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer. 2007 Academic Article GET IT
Times cited: 38
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology. 2007 Academic Article GET IT
Times cited: 151
Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiforme. 2007 GET IT
Times cited: 46
Capecitabine therapy of central nervous system metastases from breast cancer. Journal of neuro-oncology. 2007 Academic Article GET IT
Times cited: 131
Multifocal strokes as the presentation of occult lung cancer. 2007 GET IT
Times cited: 24
Treatment of primary central nervous system lymphoma. Current treatment options in neurology. 2007 Academic Article GET IT
Times cited: 8
Chemotherapy for low-grade gliomas: emerging consensus on its benefits. Neurology. 2007 Editorial Article GET IT
Times cited: 19
Treatment of primary central nervous system lymphoma. Current neurology and neuroscience reports. 2007 Review GET IT
Times cited: 5
Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro-oncology. 2007 Academic Article GET IT
Times cited: 96
Retinopathy in survivors of primary central nervous system lymphoma. Neurology. 2006 Academic Article GET IT
Times cited: 6
An update on primary central nervous system lymphoma. Hematology/oncology clinics of North America. 2006 Academic Article GET IT
Times cited: 22
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 432
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 242
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 145
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. Journal of neuro-oncology. 2006 Academic Article GET IT
Times cited: 54
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 348
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 146
Cognitive functions in low-grade gliomas: disease and treatment effects. Journal of neuro-oncology. 2006 Academic Article GET IT
Times cited: 78
Use of Diffusion Weighted MRI in Predicting Early Post-Operative Outcome of a New Neurological Deficit after Brain Tumor Resection. Neurosurgery. 2006 Academic Article GET IT
Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection. Neurosurgery. 2006 Academic Article GET IT
Times cited: 38
Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology. 2006 Academic Article GET IT
Times cited: 83
Neurologic complications of cancer chemotherapy. Seminars in oncology. 2006 Review GET IT
Times cited: 55
Response to chemotherapy of a radiation-induced glioblastoma multiforme. 2006 GET IT
Times cited: 7
Stroke in cancer patients. Current neurology and neuroscience reports. 2006 Review GET IT
Times cited: 43
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro-oncology. 2006 Academic Article GET IT
Times cited: 38
An update on therapy of primary central nervous system lymphoma. Hematology. American Society of Hematology. Education Program. 2006 Review GET IT
Times cited: 29
Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis. Cancer. 2005 Academic Article GET IT
Times cited: 98
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 218
Delayed neurotoxicity in primary central nervous system lymphoma. Archives of neurology. 2005 Academic Article GET IT
Times cited: 213
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 54
Central nervous system cancers: Clinical Practice Guidelines in Oncology. 2005 GET IT
Times cited: 53
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. Journal of neuro-oncology. 2005 Academic Article GET IT
Times cited: 73
Treatment of primary central nervous system lymphoma. Hematology/oncology clinics of North America. 2005 Review GET IT
Times cited: 25
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 619
Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology. 2005 Academic Article GET IT
Times cited: 98
Necrotizing vasculopathy of the CNS: case report. 2005 GET IT
Chemotherapy for brain tumors--a new beginning. The New England journal of medicine. 2005 Editorial Article GET IT
Times cited: 75
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2005 Letter GET IT
Times cited: 1
ACCO: ASCO core curriculum outline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 33
Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. Anti-cancer drugs. 2005 Academic Article GET IT
Times cited: 18
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Neurology. 2005 Academic Article GET IT
Times cited: 74
Leptomeningeal metastasis. Cancer investigation. 2005 Review GET IT
Times cited: 97
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. Journal of neuro-oncology. 2005 Academic Article GET IT
Times cited: 43
Treatment of primary central nervous system lymphoma. Seminars in oncology. 2004 Review GET IT
Times cited: 64
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2004 Review GET IT
Times cited: 180
Brain cancer and sexual health: a case report. 2004 GET IT
Times cited: 18
Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. British journal of haematology. 2004 Academic Article GET IT
Times cited: 121
Primary CNS lymphoma: is there a role for prophylaxis against lymphomatous meningitis?. Expert review of neurotherapeutics. 2004 Review GET IT
Times cited: 3
Stroke in patients with cancer: incidence and etiology. Neurology. 2004 Review GET IT
Times cited: 292
Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities. Archives of neurology. 2004 Academic Article GET IT
Times cited: 35
Cognitive functions in survivors of primary central nervous system lymphoma. Neurology. 2004 Academic Article GET IT
Times cited: 176
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology. 2004 Review GET IT
Times cited: 145
Treatment of brain metastases. The journal of supportive oncology. 2004 Review GET IT
Times cited: 27
Benefits of adjuvant chemotherapy in high-grade gliomas. Seminars in oncology. 2003 Review GET IT
Times cited: 27
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 254
Primary central nervous system lymphoma: a curable brain tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Editorial Article GET IT
Times cited: 21
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. Journal of neuro-oncology. 2003 Academic Article GET IT
Times cited: 30
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings. Clinical advances in hematology & oncology : H&O. 2003 Academic Article GET IT
Times cited: 10
Primary ocular lymphoma: clinical features, diagnosis, and treatment. Clinical lymphoma. 2003 Review GET IT
Times cited: 46
Prophylactic anticonvulsants in patients with brain tumour. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2003 Academic Article GET IT
Times cited: 142
Brain metastases. Neurologic clinics. 2003 Review GET IT
Times cited: 234
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 602
Neurologic complications of leukemia. Current opinion in neurology. 2002 Review GET IT
Times cited: 29
Primary CNS lymphoma: a whole-brain disease?. Neurology. 2002 Academic Article GET IT
Times cited: 153
Delayed infection of the Ommaya reservoir. 2002 GET IT
Times cited: 7
High-grade gliomas in patients with prior systemic malignancies. Cancer. 2002 Academic Article GET IT
Times cited: 26
Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?. Journal of neuro-oncology. 2002 Academic Article GET IT
Times cited: 160
A better way to find tumor in the CSF?. Neurology. 2002 Editorial Article GET IT
Times cited: 17
Nervous system neoplasms. Advances in neurology. 2002 Review GET IT
Times cited: 1
Primary central nervous system T-cell lymphoma. 2001 GET IT
Times cited: 55
Altered mental state and nonconvulsive status epilepticus in patients with cancer. Archives of neurology. 2001 Letter GET IT
Times cited: 25
Primary central nervous system lymphomas. Current treatment options in oncology. 2001 Review GET IT
Times cited: 33
Leptomeningeal metastasis from an intracranial epidermoid cyst. 2001 GET IT
Times cited: 19
Weighing the benefits and risks of radiation therapy for low-grade glioma. Neurology. 2001 Editorial Article GET IT
Times cited: 13
Brain tumors. The New England journal of medicine. 2001 Review GET IT
Times cited: 1508
Altered mental status in patients with cancer. Archives of neurology. 2000 Academic Article GET IT
Times cited: 114
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions. Neurosurgery. 2000 Academic Article GET IT
Times cited: 263
Treatment for primary CNS lymphoma: the next step. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 551
Neurologic emergencies in the cancer patient. Seminars in oncology. 2000 Review GET IT
Times cited: 57
Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000 Academic Article GET IT
Times cited: 296
Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000 Academic Article GET IT
Times cited: 105
Radiotherapy of the brain in elderly patients. arbiter:. European journal of cancer (Oxford, England : 1990). 2000 Academic Article GET IT
Times cited: 6
Update on the management of primary CNS lymphoma. Oncology (Williston Park, N.Y.). 2000 Review GET IT
Times cited: 67
Neoplasms. Current opinion in neurology. 1999 Editorial Article GET IT
Primary central nervous system lymphoma. Current opinion in neurology. 1999 Review GET IT
Times cited: 53
Metastatic Disease of the Nervous System. Current treatment options in neurology. 1999 Academic Article GET IT
Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. Journal of neuro-oncology. 1999 Review GET IT
Times cited: 88
Malignant glioma: who benefits from adjuvant chemotherapy?. Annals of neurology. 1999 Letter GET IT
Primary central nervous system lymphoma. Journal of neurology, neurosurgery, and psychiatry. 1999 Editorial Article GET IT
Times cited: 27
111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology. 1999 Letter GET IT
Times cited: 51
Herpes varicella zoster encephalitis in immunocompromised patients. Neurology. 1999 Academic Article GET IT
Times cited: 25
Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Annals of oncology : official journal of the European Society for Medical Oncology. 1999 Academic Article GET IT
Times cited: 45
Telomerase activity in brain and leptomeningeal metastases. Journal of the neurological sciences. 1998 Editorial Article GET IT
Times cited: 3
Adult brainstem gliomas. Neurology. 1998 Academic Article GET IT
Times cited: 76
Malignant glioma: who benefits from adjuvant chemotherapy?. Annals of neurology. 1998 Academic Article GET IT
Times cited: 126
Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy. Journal of neuro-oncology. 1998 Review GET IT
Times cited: 20
Steroid myopathy in cancer patients. Neurology. 1998 Letter GET IT
Aging and primary central nervous system neoplasms. Neurologic clinics. 1998 Review GET IT
Times cited: 7
Brain abscesses in children with cancer. Medical and pediatric oncology. 1998 Academic Article GET IT
Times cited: 30
Radiotherapy at tumor recurrence in primary CNS lymphoma. Neurology. 1998 Letter GET IT
Times cited: 8
Brain tumor therapy: new horizons, new hope. Neurology. 1998 Editorial Article GET IT
Times cited: 3
Hydrocephalus in radiation leukoencephalopathy: results of ventriculoperitoneal shunting. Archives of neurology. 1998 Academic Article GET IT
Times cited: 59
Long-term survival in primary CNS lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 489
111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology. 1998 Academic Article GET IT
Times cited: 81
Biology and treatment of malignant glioma. Oncology (Williston Park, N.Y.). 1998 Review GET IT
Times cited: 64
Current diagnosis and treatment of leptomeningeal metastasis. Journal of neuro-oncology. 1998 Review GET IT
Times cited: 186
NCCN adult brain tumor practice guidelines. Oncology (Williston Park, N.Y.). 1997 Academic Article GET IT
Times cited: 14
Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology. 1997 Review GET IT
Times cited: 33
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. Journal of neuro-oncology. 1997 Academic Article GET IT
Times cited: 158
Steroid myopathy in cancer patients. Neurology. 1997 Academic Article GET IT
Times cited: 175
Neuroimaging abnormalities with hypoglossal nerve palsies. 1997 GET IT
Times cited: 8
Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement. Retina (Philadelphia, Pa.). 1997 Academic Article GET IT
Times cited: 40
Biology and management of AIDS-associated primary CNS lymphomas. Hematology/oncology clinics of North America. 1996 Review GET IT
Times cited: 46
Neuroimaging abnormalities with hypoglossal nerve palsies. 1996 GET IT
Times cited: 1
Docetaxel neuropathy. Neurology. 1996 Letter GET IT
Times cited: 1
Carboxypeptidase G2 rescue after high-dose methotrexate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 51
Medical management of cerebral metastases. Neurosurgery clinics of North America. 1996 Review GET IT
Times cited: 43
Motor neuropathy due to docetaxel and paclitaxel. Neurology. 1996 Academic Article GET IT
Times cited: 133
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology. 1996 Academic Article GET IT
Times cited: 41
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology. 1996 Academic Article GET IT
Times cited: 206
Low-grade oligodendroglioma responds to chemotherapy. Neurology. 1996 Academic Article GET IT
Times cited: 197
Primary central nervous system lymphoma: curable without toxicity?. The cancer journal from Scientific American. 1996 Comment GET IT
Times cited: 1
Primary brain tumors in the acquired immunodeficiency syndrome. Current opinion in neurology. 1995 Review GET IT
Times cited: 12
Primary central nervous system lymphoma. Neurologic clinics. 1995 Review GET IT
Times cited: 35
Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Annals of neurology. 1995 Academic Article GET IT
Times cited: 138
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer. 1995 Academic Article GET IT
Times cited: 106
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Annals of neurology. 1995 Academic Article GET IT
Times cited: 357
Current management of primary central nervous system lymphoma. Oncology (Williston Park, N.Y.). 1995 Review GET IT
Times cited: 91
Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology. 1994 Academic Article GET IT
Times cited: 106
Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma. 1994 GET IT
Times cited: 30
Therapy of venous thromboembolism in patients with brain metastases. Cancer. 1994 Academic Article GET IT
Times cited: 149
Central nervous system neoplasms in pregnancy. Advances in neurology. 1994 Review GET IT
Times cited: 26
Management of brain metastases. Cancer investigation. 1994 Review GET IT
Times cited: 51
Primary central nervous system lymphoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1994 Review GET IT
Times cited: 23
The clinical spectrum of ocular lymphoma. Cancer. 1993 Academic Article GET IT
Times cited: 253
Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Annals of neurology. 1993 Academic Article GET IT
Times cited: 79
Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. 1993 GET IT
Times cited: 242
Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer. 1992 Academic Article GET IT
Times cited: 58
Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy. 1992 GET IT
Times cited: 19
Combined modality therapy for primary CNS lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 503
The spectrum of neurological disease in patients with systemic cancer. Annals of neurology. 1992 Review GET IT
Times cited: 176
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside. Cancer chemotherapy and pharmacology. 1992 Academic Article GET IT
Times cited: 35
Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response. Cancer chemotherapy and pharmacology. 1992 Academic Article GET IT
Times cited: 18
Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma. Cancer. 1991 Academic Article GET IT
Times cited: 61
Primary central nervous system lymphoma: a new clinical challenge. Neurology. 1991 Editorial Article GET IT
Times cited: 72
Primary central nervous system lymphoma as a secondary malignancy. 1991 GET IT
Times cited: 40
Primary central nervous system lymphoma imitates multiple sclerosis. 1990 GET IT
Times cited: 61
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology. 1990 Academic Article GET IT
Times cited: 269
The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology. 1990 Academic Article GET IT
Times cited: 120
The combined use of radiation therapy and lonidamine in the treatment of brain metastases. Journal of neuro-oncology. 1989 Academic Article GET IT
Times cited: 80
Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989 Academic Article GET IT
Times cited: 801
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery. 1989 Academic Article GET IT
Times cited: 248
Lymphomatous meningitis presenting as atypical cluster headache. 1987 GET IT
Times cited: 22
Primary CNS lymphoma: managing patients with spontaneous and AIDS-related disease. Oncology (Williston Park, N.Y.). 1987 Review GET IT
Times cited: 28
Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia. 1987 GET IT
Times cited: 46
Intracranial tuberculoma: case report and review of the literature. 1981 GET IT
Times cited: 95
Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells. Cancer treatment reports. 1977 Academic Article GET IT
Times cited: 11
Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists. Cancer research. 1976 Academic Article GET IT
Times cited: 25
5-methyl-5,6,7,8-tetrahydropteroyl oligo-gamma-L-glutamates: synthesis and kinetic studies with methionine synthetase from bovine brain. Biochemistry. 1975 Academic Article GET IT
Times cited: 57

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1980
A.B., Wellesley College 1977

Contact

full name

Lisa M. DeAngelis

VIVO Weill Cornell Medical College

Lisa M. DeAngelis Professor of Neurology

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name